Although only a limited number of samples had complete transcriptional, genomic and clinical data, we found that dichotomizing ETV6 levels (above/below median expression) was of prognostic importance only in DLBCL patients but not in BL or MCL patients (Figure 4G). This evidence concerns the gene ETV6 and mantle cell lymphoma.